ArticleFrontiers in neurology

Real-world use of efgartigimod in acetylcholine receptor antibody-positive generalized myasthenia gravis: experience from two centers in Greece and Cyprus.

Tasos Tsokkos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.